Bachelor vet Hannah Brown reveals 'shocking' double uterus diagnosis
Former Bachelorette Hannah Brown revealed that she was diagnosed with a rare uterine abnormality that affects only 0.3 percent of the female population.
While appearing on Maria Menounos' podcast, Heal Squad, the reality star opened up about finding out that she has a double uterus at age 30.
'It was definitely a shock,' the God Bless This Mess said of her health condition, before detailing how it may affect her fertility down the line.
While she has not undergone the exploratory surgery to learn more about her double uterus, Brown explained 'it looks like they're attached in some way.'
'It's just like a split,' Brown, who is set to wed fiancé Adam Woolard, told Menuonos, said.
While she hasn't 'quite gotten to' the stage of wanting to have a child, just yet, the TV personality noted her doctor advised she freezes her eggs soon.
Brown said after she gets married this year, she 'will get right on that.'
Women, who have a double uterus (uterus didelphys), do have an increased risk of pregnancy complications, such as miscarriage and preterm birth.
The condition can also potentially affect fertility as some women with it may experience difficulties conceiving.
Others, however, many others have no issues getting pregnant and can carry to term, according to Mayo Clinic.
Despite the possibility of some complications, Brown pointed out: 'There have been cases of people having double uteruses and having babies and being perfectly fine.'
Although the news took her by surprise, she is grateful for the knowledge as she figures out her future plans.
'I definitely think I would love to have a child, and I don't want to miss out on that experience,' she said. 'But I haven't been quite ready yet, which I think makes sense. I want to get married first. I want to be able to do that.'
'I've never been to just like, just waiting, waiting, waiting for that to happen,' she continued. 'But I do think I'll I'm going to want to have that experience, when it's time.'
Back in 2021, Brown revealed in her memoir that she was diagnosed with pancreatic cancer at age 11 and underwent a surgery which removed the tumor.
When she was in fifth grade, she underwent an MRI in order to find out what had been causing her frequent stomach aches. However, the procedure revealed she had a 'tumor the size of an egg' on her pancreas.
'They sent me for a biopsy, and a day or so later, my dad got a call with the results — not from our regular doctor, but from an oncologist. The tumor was malignant. Cancer. Pancreatic cancer — one of the deadliest forms of cancer there is,' she said.
However, Brown was given some peace of mind after the oncologist informed her the cancer had not spread.
'On the day of my surgery, I wasn't scared about what was going to happen to me. At all,' Hannah wrote. 'Even though my mother was in tears and my dad looked as worried as I'd ever seen him in my life as the nurses came to wheel me into the operating room, I looked up at my mom from my hospital bed and said, "Mama, I'm going to be okay."'
The tumor was entirely removed during the procedure and she did not have to go through radiation and chemotherapy.
Brown also previously revealed that she suffers from 'horrible and haunting' sleep paralysis, narcolepsy, inflammation, anxiety and PCOS.
In her book, she speculated that her battle with narcolepsy was 'a direct symptom of the trauma of' learning her aunt LeeLee and her two young cousins, Robin and Trent, were murdered.
Additionally, she has been open about suffering from asthma since she was five.
In December 2022, she had an asthma attack on a flight that was so severe her plane had to be 'diverted' and she was met with a stretcher.
'I was shaking uncontrollably and trying to grab my inhaler — but I couldn't take in the air,' she told People. 'It was embarrassing.'
Brown told the outlet that she feels like she 'spent most' of her 'childhood in a doctor's office, doing my homework and playing I Spy.'
'I was a pretty sick kid, catching everything going around school,' she explained.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
'I've never smoked and I'm teetotal - yet I've become addicted to vaping in my 60s.' MARY KILLEN on her compulsive habit
The other day I was congratulating myself for the fact that I seem perfectly able to spring out of bed at around 6am each morning, even when I've been up till 2am. 'I must be quite fit,' I told myself. Then the reason I can get up so early dawned on me. It's because my body has woken me. It wants to see action because it wants more nicotine to be delivered via my electronic cigarette. I began vaping a couple of years ago when the rather cool 22-year-old son of a friend offered me a puff of his Juul, which is an elegant black rectangular stick.
Daily Mail
7 hours ago
- Daily Mail
Walmart recalls item they warn to 'dispose of immediately' after reports of burn injuries
Walmart has recalled a range of electric blankets after reports they have caught fire and caused serious burns. The grocery giant has been forced to recalled the MaxKare Electric Blankets after the Consumer Product Safety Commission (CPSC) received reports from consumers that the blankets had overheated, caught fire and caused serious burn injuries. The blankets, available in brown and gray, were sold exclusively online by Walmart between June 2021 and November 2024. They came in twin, full, queen sizes costing between $27 to $80. The roughly 8,500 items effected by the recall notice will bear the model numbers HB18A-7284-1, HB18A-8490-2 or HB18A-6284-1 which can be found on the blanket's label. The retailer has urged anyone who bought the effected products to dispose of them immediately. Those that wish to seek refunds can contact the blanket's manufacturer Shenzhen Yumo Commerce. 'Walmart and Sam's Club are committed to the health and safety of our customers and members and to providing products that are safe and compliant, all supported by our health and wellness, product safety, and food safety professionals,' the retailer said in a statement regarding the latest recall. 'In the event of a product recall, we work swiftly to block the item from being sold and remove it from our stores and clubs.' It comes as federal officials announced they have launched an investigation into the deaths of three people and a pregnancy loss connected to ready meals sold at retail giants Walmart and Kroger. Food distributor FreshRealm announced earlier this week that it would be recalling its chicken fettuccine alfredo products over listeria concerns. The US Food Safety and Inspection Service (FSIS) is now investigating the outbreak, which has sickened 17 people in 13 states. The affected products include 32.8oz and 12.3oz trays of Marketside Grilled Chicken Alfredo with Fettucine pasta with best-by dates of June 26 and 27, 2025. Also included in the recall is 12.5oz trays of Home Chef Heat & Eat Chicken Fettucine Alfredo pasta with a best-by date of June 19,2025 or before. The meals are sold nationwide at Walmart, under the Marketside brand, and Kroger, under the Home Chef brand. A listeria infection usually causes fever, headache and diarrhea in most people, but it can be deadly for pregnant women, newborns, the elderly and those with weak immune systems. Federal officials launched an investigation into the deaths of three people and a pregnancy loss connected to ready meals sold at Walmart Earlier this year Walmart was forced to recall its Marketside celery sticks from stores in 29 states over possible listeria contamination. The issue was discovered during a random sampling by the Georgia Department of Agriculture. A month later Walmart was also embroiled in another mass recall of canned tuna over a potentially fatal food poisoning risk. Tri-Union Seafoods announced the recall after its supplier informed the company that the cans' 'easy open' pull tab lids have a manufacturing defect.
The Independent
8 hours ago
- The Independent
Weight loss pill shows promise in new trial
A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
